Revitalizing Treg Function in Autoimmunity: An Innovative Protein Drug Conjugate Platform

Time: 11:30 am
day: Day One AM Non-Cell Based Approaches


  • IL-2Rx has developed a platform of IL-2 fusion protein-based therapeutics known as Protein Drug Conjugates (PDC) designed to restore Treg function in autoimmunity
  • These PDCs carry detachable small molecule neddylation activating enzyme inhibitors, that restore or enhance autoimmune Treg function